← Leaderboards
John Dong-Hoon Hong
University Of California-Irvine
$194,555
Attributed
$194,555
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$194,555 · 1
By mechanism
F30$194,555 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Krzysztof Palczewski$52,410,190
- Marcelo Andres Wood$22,715,150
- Thomas F Schilling$18,101,864
- Philip David Kiser$2,423,692
- Gregory A. Weiss$6,550,549
Others in their field
Other Rising Stars on “Dimer”
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
- Chi-Lun Chang · St. Jude Children'S Research Hospital$2,748,000
- Patricia Manuela Ribeiro Pereira · Washington University$1,869,482
- Jennifer Ann Frontera · New York University School Of Medicine$1,839,413
- Gehan Devendra · University Of Hawaii At Manoa$1,723,721
- Reza Dastvan · Saint Louis University$1,659,998
Research focus
Dimer11 Cis RetinalAdolescentAbsorptionAdductAll-Trans-RetinolAlpha Subunit TransducinAmericanAnalogAffectAge Related Macular DegenerationBackBindingBlindnessBruch&AposChildChromophoreComplexContact LensesCrosslinkDangerousnessAttenuatedDepositionDimerization
Grant awards (4)
Formation of Retinyl-Opsins by Retinyl Formate as Molecular Shades Against Light-Induced Retinal Damage$54,538
F30 · FY2025 · EY · contact PI
Formation of Retinyl-Opsins by Retinyl Formate as Molecular Shades Against Light-Induced Retinal Damage$53,974
F30 · FY2024 · EY · contact PI
Formation of Retinyl-Opsins by Retinyl Formate as Molecular Shades Against Light-Induced Retinal Damage$43,836
F30 · FY2023 · EY · contact PI
Formation of Retinyl-Opsins by Retinyl Formate as Molecular Shades Against Light-Induced Retinal Damage$42,207
F30 · FY2022 · EY · contact PI